Ping Chen Selected Research

Bronchodilator Agents (Bronchodilators)

12/2016	Current situation of asthma-COPD overlap syndrome (ACOS) in Chinese patients older than 40 years with airflow limitation: rationale and design for a multicenter, cross-sectional trial (study protocol).
8/2014	[Prevention of acute exacerbation of chronic obstructive pulmonary disease].
3/2014	Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
4/2013	High-dose N-acetylcysteine in the prevention of COPD exacerbations: rationale and design of the PANTHEON Study.
10/2010	Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China.
6/2010	Asymptomatic patients of chronic obstructive pulmonary disease in China.
5/2009	[Current status of prevention and management of chronic obstructive pulmonary disease in rural area in China].
4/2009	[The quality of life of patients with chronic obstructive pulmonary disease and correlated factors].
12/2007	The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
10/2007	Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Chen Research Topics

Disease

356	Neoplasms (Cancer) 04/2024 - 02/2003
91	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 05/2005
72	Inflammation (Inflammations) 05/2024 - 01/2002
65	Neoplasm Metastasis (Metastasis) 03/2023 - 05/2009
57	Infections 04/2024 - 03/2004
47	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 08/2010
38	Fibrosis (Cirrhosis) 03/2024 - 08/2004
38	Stomach Neoplasms (Stomach Cancer) 02/2024 - 11/2006
36	Breast Neoplasms (Breast Cancer) 12/2023 - 10/2004
36	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 12/2002
33	Lung Neoplasms (Lung Cancer) 11/2023 - 02/2003
31	Colorectal Neoplasms (Colorectal Cancer) 05/2023 - 07/2008
30	Carcinoma (Carcinomatosis) 01/2022 - 10/2004
27	Hypoxia (Hypoxemia) 03/2024 - 11/2006
26	Leukemia 01/2022 - 09/2003
25	Carcinogenesis 02/2024 - 02/2003
25	Asthma (Bronchial Asthma) 01/2023 - 06/2003
23	Pain (Aches) 12/2023 - 02/2006
21	Hypertension (High Blood Pressure) 02/2024 - 06/2012
20	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 05/2010
19	Pneumonia (Pneumonitis) 03/2024 - 01/2006
19	Multiple Myeloma 03/2024 - 12/2006
19	Emphysema 01/2024 - 04/2009
19	COVID-19 12/2023 - 01/2020
17	Adenocarcinoma 03/2023 - 05/2011
16	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 06/2002
15	Type 2 Diabetes Mellitus (MODY) 02/2024 - 07/2004
15	Wounds and Injuries (Trauma) 08/2023 - 10/2015
15	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 07/2009
15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2008
14	Adenocarcinoma of Lung 01/2024 - 01/2002
14	Necrosis 10/2022 - 06/2004
14	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022 - 02/2003
14	Hemorrhage 01/2022 - 07/2011
14	Esophageal Squamous Cell Carcinoma 01/2022 - 05/2005
13	Liver Cirrhosis (Hepatic Cirrhosis) 05/2024 - 08/2010
13	Liver Neoplasms (Liver Cancer) 03/2024 - 10/2012
13	Stroke (Strokes) 08/2023 - 01/2019
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 06/2012
12	Obesity 03/2024 - 05/2009
12	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 09/2015
12	Colonic Neoplasms (Colon Cancer) 01/2023 - 06/2011
12	Thalassemia 01/2022 - 08/2009
11	Body Weight (Weight, Body) 02/2024 - 03/2009
11	Reperfusion Injury 12/2023 - 02/2006
11	Thrombosis (Thrombus) 01/2023 - 10/2015
11	Myocardial Infarction 01/2017 - 12/2003
10	Ischemia 12/2023 - 05/2010
10	Dyspnea (Shortness of Breath) 01/2021 - 02/2006

Drug/Important Bio-Agent (IBA)

135	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2002
61	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2003
52	MicroRNAs (MicroRNA)IBA 12/2023 - 10/2008
43	Messenger RNA (mRNA)IBA 04/2024 - 01/2004
40	CytokinesIBA 02/2024 - 05/2004
35	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2002
33	SmokeIBA 01/2024 - 10/2002
27	Long Noncoding RNAIBA 01/2023 - 10/2014
25	RNA (Ribonucleic Acid)IBA 02/2024 - 08/2010
24	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 12/2002
22	Therapeutic UsesIBA 04/2023 - 02/2006
21	EnzymesIBA 01/2023 - 05/2007
21	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 01/2005
20	Small Interfering RNA (siRNA)IBA 01/2021 - 08/2010
19	AntioxidantsIBA 04/2023 - 10/2007
18	Peptides (Polypeptides)IBA 04/2023 - 01/2002
17	AntigensIBA 03/2024 - 12/2010
17	GoldIBA 12/2023 - 03/2014
17	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 02/2003
16	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 07/2004
14	Interleukin-6 (Interleukin 6)IBA 11/2023 - 12/2009
13	Phosphotransferases (Kinase)IBA 04/2024 - 05/2002
13	Indicators and Reagents (Reagents)IBA 12/2023 - 05/2005
13	Gemcitabine FDA Link 01/2023 - 12/2002
13	Bronchodilator Agents (Bronchodilators)IBA 12/2016 - 07/2005
12	Hemoglobins (Hemoglobin)IBA 02/2024 - 04/2004
12	LipidsIBA 02/2024 - 12/2010
12	Transcription Factors (Transcription Factor)IBA 02/2023 - 01/2008
12	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 07/2005
12	C-Reactive ProteinIBA 08/2022 - 08/2005
12	Oxygen (Dioxygen)IBA 11/2021 - 08/2011
11	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 12/2005
11	VaccinesIBA 12/2023 - 03/2004
11	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2023 - 02/2015
11	Tumor Biomarkers (Tumor Markers)IBA 04/2023 - 10/2004
11	Paclitaxel (Taxol)FDA LinkGeneric 02/2023 - 04/2008
10	AntibodiesIBA 03/2024 - 05/2005
10	Protein Isoforms (Isoforms)IBA 01/2024 - 04/2006
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 07/2004
10	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
9	Blood Glucose (Blood Sugar)IBA 02/2024 - 08/2006

Therapy/Procedure

165	Therapeutics 05/2024 - 07/2005
64	Drug Therapy (Chemotherapy) 02/2024 - 12/2002
27	Immunotherapy 12/2023 - 11/2007
19	Radiotherapy 02/2023 - 08/2003
17	Transplantation 01/2024 - 11/2004
16	Length of Stay 01/2023 - 02/2006
15	Splenectomy 01/2019 - 01/2014
11	Aftercare (After-Treatment) 09/2023 - 03/2003
11	Adjuvant Chemotherapy 05/2023 - 10/2009
9	Intraperitoneal Injections 01/2024 - 12/2009